arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up

Serina Therapeutics, Inc.

SER Health Care Biotechnology: Pharmaceutical Preparations
$1.73
▼ -2.3% Today
as of Oct 23, 13:06 ET
Last 30 days -29.39% Sep 14 → Oct 23
$1.59 $1.82 $2.05 $2.28 $2.51 Sep 14 Sep 22 Sep 30 Oct 07 Oct 15 Oct 23
Open
$1.73
High
$1.80
Low
$1.73
Volume
$51,258
Avg Vol
$1M
Mkt Cap
$50M
P/E (TTM)
—
Beta
—
52w High
$5.29
52w Low
$1.22
Div Yield
—
Shares Out
$25M

Recent Press Releases & News last 60 days · 2 items

SER earnings at a glance

Over its last 2 reports the stock rose the next day 1 time and fell 1, moving ±5.2% on average; after the most recent report on May 14, 2026 it moved +10.3%. SER beat the consensus EPS estimate in 1 of its last 2 reported quarters. The share price of $1.73 sits near its 52-week low.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$1.22
$5.29
13% of range
Avg surprise (last 2)
-39.5%
Avg reaction (last 2)
+5.1%
50% positive

Earnings trends

EPS — actual vs estimate Actual Estimate
$-5.38$-3.91$-2.44$-0.96$0.51 Actual $0.20Actual $0.11Actual $0.23Actual $-5.38Actual $0.51Actual $0.13Actual $-0.49Actual $-0.66Est $-0.36Actual $-0.45Est $-0.47Actual $-0.58Actual $-0.55 MarJunSepMarJunSepMar/2025Jun/2025Sep/2025Mar/2026Jun
Revenue vs Net Income Revenue Net income
$-7M$-5M$-3M$-614,125$1M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-0.55 — — — — financials
Thu May 14, 2026Mar/2026 $-0.58 — — -18.4% +10.3% earnings
Thu Nov 13, 2025Sep/2025 $-0.45 $-0.47 +4.3% — — earnings
Mon Aug 11, 2025Jun/2025 $-0.66 $-0.36 -83.3% — — earnings
Thu May 8, 2025Mar/2025 $-0.49 — — — -0.1% earnings
Mon Sep 30, 2024Sep 2024 $0.13 — — — — financials
Sun Jun 30, 2024Jun 2024 $0.51 — — — — financials
Sun Mar 31, 2024Mar 2024 $-5.38 — — — — financials
Sat Sep 30, 2023Sep 2023 $0.23 — — — — financials
Fri Jun 30, 2023Jun 2023 $0.11 — — — — financials
Fri Mar 31, 2023Mar 2023 $0.20 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$0——$0$130,000$0—$14,000
Cost of revenue————————
Gross profit————————
Operating income$-7M——$-6M$-6M$-6M—$-5M
Net income$-6M$-7M—$-5M$-6M$-5M—$1M
EPS (diluted)$-0.55$-0.58—$-0.45$-0.66$-0.49—$0.13

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$23M$25M$3M$9M$6M$4M$4M$3M
Inventory————————
Total current assets$25M$26M$6M$11M$8M$6M$6M$5M
Total assets$26M$27M$7M$12M$9M$7M$7M$7M
Long-term debt———————$11M
Total liabilities$7M$10M$7M$11M$7M$5M$6M$21M
Total equity$19M$18M$-37,000$2M$2M$2M$641,000$-14M

Implied volatility — last 90 days

No IV snapshots yet for SER.

IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.

Sector peers

SER earnings FAQ

How does SER stock usually react to earnings?

Across the last 2 reports the average next-day move was ±5.2%, up 1 times and down 1 times.

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.